What's breaking now, across thousands of outlets.
Key PointsViking Therapeutics is studying its weight-loss drug candidate in phase 3 trials.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
The selloff in global government bonds accelerated in European midday trade, pushing yields on 10-year German Bunds and Treasurys to fresh multiyear highs.
Key PointsNvidia more than doubled its revenue year over year and anticipates 70% growth in fiscal year 2028.
Key PointsCoca-Cola has raised its dividend annually for the past 64 years.
Bond buyback leaves investors underwhelmed.
My morning reads: • Something Is Shifting in the Inflation Picture: Claudia Sahm on why she moved from hold to hike ahead of next week’s Fed meeting — a division no single CPI print will resolve.
(RTTNews) - German stocks turned in a mixed performance on Thursday with investors digesting the nation's inflation data and awaiting the European Central Bank's monetary policy announcement later in…
